Aurora Cannabis (TSE:ACB) Rating Lowered to Sell at TD

Aurora Cannabis (TSE:ACB) was downgraded by research analysts at TD from a “buy” rating to a “sell” rating in a note issued to investors on Wednesday, BayStreet reports. They presently have a C$7.80 price target on the stock, down from their prior price target of C$8.00. TD‘s target price suggests a potential upside of 7.14% from the stock’s current price.

ACB has been the topic of a number of other reports. ATB Cormark Capital Markets boosted their target price on shares of Aurora Cannabis from C$5.60 to C$7.00 and gave the stock a “tender” rating in a research report on Tuesday, October 6th. BMO Capital Markets raised shares of Aurora Cannabis to a “hold” rating in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Aurora Cannabis presently has a consensus rating of “Hold” and a consensus price target of C$6.60.

Aurora Cannabis Stock Up 1.0%

Aurora Cannabis stock traded up C$0.07 during midday trading on Wednesday, hitting C$7.28. 969,759 shares of the company were exchanged, compared to its average volume of 414,833. The company has a market cap of C$451.05 million, a PE ratio of -3.75 and a beta of 0.64. Aurora Cannabis has a fifty-two week low of C$3.59 and a fifty-two week high of C$8.75. The company’s fifty day moving average price is C$5.72 and its 200-day moving average price is C$4.94. The company has a debt-to-equity ratio of 4.30, a current ratio of 5.36 and a quick ratio of 2.48.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Wednesday, August 5th. The company reported C($0.07) earnings per share (EPS) for the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. The firm had revenue of C$67.55 million during the quarter. On average, research analysts predict that Aurora Cannabis will post -0.22 EPS for the current fiscal year.

About Aurora Cannabis

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty’s ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.